Adverse Event Reporting in Simple Terms
When a product used on people may have caused injury, death or a serious malfunction, the manufacturer must tell the regulator. In the US, medical device makers follow the FDA Medical Device Reporting rule (21 CFR 803). In Europe, the EU Medical Device Regulation sets vigilance reporting for serious incidents and field safety corrective actions. Pharmaceutical companies report adverse drug reactions under pharmacovigilance rules.
For the factory, an adverse event is often the start of a quality investigation: complaint, investigation, root cause analysis and CAPA.
How It Works
- Receive: a complaint or field report arrives from a user, hospital or distributor.
- Assess: decide whether the event is reportable under the rules that apply.
- Report: submit within the regulatory deadline, for example 30 calendar days for most FDA MDRs and shorter limits for serious public health threats.
- Investigate: check lot records, traceability data and the process to find the cause.
- Act and follow up: contain affected stock, correct the cause and send follow-up reports.
Deadlines differ by regulator and event type, so each company should confirm them against the current regulation text.
Example
A hospital reports that an infusion pump housing cracked during use and a patient received a delayed dose. The manufacturer logs the complaint, decides it is reportable, files the report on time, traces the housing to one moulding lot, finds a low mould temperature setting and opens a CAPA to add a temperature check to the control plan.
Why It Matters
- Regulators use reports to spot product problems across the market.
- Late or missing reports can lead to warning letters and recalls.
- A good report depends on good manufacturing records, such as lot history and inspection results.
Inside the plant, OperaHive incident reporting software records incidents, investigations and corrective actions, which can support the internal side of this work; regulatory submissions are made through the regulator's own channels.